Feedback PLC Bleepa-CareLocker contract extension with QVH (2338V)
April 04 2023 - 2:00AM
UK Regulatory
TIDMFDBK
RNS Number : 2338V
Feedback PLC
04 April 2023
Feedback plc
Bleepa-CareLocker contract extension with Queen Victoria
Hospital
Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the
specialist clinical communication company, announces that it has
been awarded a nine-month, fixed-term contract extension of its
contract for the Sussex Health and Care Partnership Integrated Care
System ("Sussex ICS") development programme with Queen Victoria
Hospital ("QVH") for Feedback's Bleepa-CareLocker Community
Diagnostics Centre ("CDC") solution.
This paid extension, which follows the success of the Company's
existing contract (details of which were announced by Feedback on 6
September 2022), follows the abandonment of the Trust's previous
procurement process in March 2023 and will cover the period from 1
April 2023 until 31 December 2023 whilst QVH undertakes a new
tender exercise under the Public Contracts Regulations 2015. A new
tender process for the next phase of the CDC programme rollout is
due to commence imminently.
QVH is expected to procure the relevant components of the CDC
programme, including the digital pathway element, currently under
contract with Feedback.
Dr Tom Oakley, CEO Feedback plc said: "Although QVH had expected
to conclude its tender process by 31(st) March 2023, we have been
informed by the Trust that the existing tender process is no longer
progressing. We are pleased to be supporting QVH on an interim
basis to ensure the continuity of ongoing patient care whist they
undertake a further procurement exercise.
"The digital component of CDC delivery that Feedback provides is
critical, and we continue to champion the QVH CDC programme to
other NHS organisations through the continuation of this contract,
and remain confident in the emerging opportunity that CDCs
represent both for the Company and the wider NHS. While we continue
to support QVH, the Company will actively explore opportunities to
support the wider CDC capability throughout the NHS."
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK
law by virtue of the European Union (Withdrawal) Act 2018.
-Ends-
Enquiries:
Feedback plc +44 (0) 20 3997 7634
Tom Oakley, CEO IR@fbk.com
Anesh Patel, CFO
Panmure Gordon (UK) Limited
(NOMAD and Broker)
Emma Earl/Freddy Crossley (Corporate
Finance)
Rupert Dearden (Corporate Broking) +44 (0)20 7886 2500
Walbrook PR Ltd; Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
Nick Rome/Joe Walker 07748 325 236 or 07407 020 470
About Feedback
Feedback plc helps clinical teams to make better decisions
faster for patients. We design products that enhance clinician
access to patient data and to their colleagues. Our unique approach
centres around individual patient episodes, into which we pull
relevant clinical data from hospital systems and around which we
build remote clinical teams for collaboration. As a result, we
produce a digital infrastructure that makes patient data available
to clinicians in multiple settings, in a format that enables them
to meaningfully interact with it, providing flexibility to
clinicians and free movement of patients between provider settings
- clinicians can practice from anywhere and patients can attend any
care provider for treatment.
Our products Bleepa and CareLocker work together to deliver
unparalleled value to our customers. Bleepa is our application
layer and sits on top of CareLocker as our data layer. Bleepa is a
clinician facing platform that displays clinical results from a
patient's CareLocker at a certified and regulated quality, that is
suitable for clinical use and enables dialogue on a
patient-by-patient basis with colleagues through a secure,
auditable chat interface that links back to the patient medical
record. The CareLocker data storage model is built around the
patient. Our vision is one where relevant clinical data is always
available to the patient as well as to any care setting that they
may attend - a federated data architecture with the patient as the
tenant.
The Company has a number of growth opportunities domestically
and internationally across a range of markets including the NHS,
the veterinary market and private healthcare providers and its
highly scalable Software as a Service ("SaaS")-based revenue model
is expected to provide increasing levels of visibility as the
Company grows its customer base.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCZZGGDGFZGFZZ
(END) Dow Jones Newswires
April 04, 2023 02:00 ET (06:00 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
From Jul 2024 to Aug 2024
Feedback (LSE:FDBK)
Historical Stock Chart
From Aug 2023 to Aug 2024